B0USP0 AF NFT

Valine--tRNA ligase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeifyqj6sezknofqtamuwm4gemkdfsya2e7ojvsq3wkxotfqv23aib4/metadata.json
IPFS of structure file: 
bafybeihb5ndkp2y5djyhnrnswznptbekpgzffu57z2w6cyplcwxkoatqwq/AF-B0USP0-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xA91f62865d77796ecce8F77c3819DD7f3122E46D
First NFT owner address (bech32): 
genesis14y0k9pjawaukan8g7a7rsxwa0ucj9erdcyr86u
Current NFT ID #454943 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
454943
Accession (UniProt):
B0USP0
Name::
Valine--tRNA ligase
Experimental Method:
Predicted structure
Sequence source:
Histophilus somni (strain 2336)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B0USP0 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B0USP0|SYV_HISS2 Valine--tRNA ligase OS=Histophilus somni (strain 2336) OX=228400 GN=valS PE=3 SV=1 MTKQFTMEDRFNPSAVEQALYQHWESRGYFKPSEDINAPSYCIAIPPPNVTGSLHMGHAFQQTLMDTLIRFNRMEGNNTLWQTGTDHAGIATQMVVERKIAAEEGKTRHDYGREAFINKIWDWKAYSGGTISQQMRRLGNSIDWDRERFTMDEGLSNAVKEVFVRLHEEGLIYRGKRLVNWDPKLHTAISDLEVENKESKGSLWHFRYPLANGAKTAEGLDYLVVATTRPETMLGDTAVAVHPEDERYQSLIGKTVVLPLANREIPIIADEYVDREFGTGVVKITPAHDFNDYEVGKRHGLPMVNVMTLNADIRAEAEIIGTDGKPLAGYDAPIPADYQGLERFVARKKIVADFEALGLLDQIKPHDLKVPYGDRGGVPIEPMLTDQWYVSVKPLAEVATKAVENGEIQFVPKQYENLYFSWMRDIQDWCISRQLWWGHRIPAWYDEQGNVYVARDEAEVRSKYGLTSDVALKQDEDVLDTWFSSGLWTFSTLGWPEQTKELKMFHPTDVLITGFDIIFFWVARMIMFTMHFIKDENGKPQVPFKTVYVTGLIRDEQGQKMSKSKGNVLDPIDMIDGISLEDLLEKRTGNMMQPQLAEKIAKATRKEFEHGISAHGTDALRFTLAALASNGRDINWDMKRLEGYRNFCNKLWNASRYVLTHEKLDLSEGEAEYSLADRWIESQFNRTIDAFRTALKQYRFDLVANTIYDFTWNQFCDWYLELTKPVFAHGTDAQKRGTSRMLLNILEKLLRLAHPIIPFITEEIWQKLKGVMKLSGDTIMLQPFPHAEESKFDPVAESQMDWLKEVIVAVRNIRAECNISPSHALELLLRNISEETKICLENNRTLLQSMAKLSTITLLDANEEPPLSVTKLVENNEIFIPMAGFINKEQELTRLTKEIEKLKGEIVRIENKLSNEAFITKAPEQVIAKEREKMQGYLDNIEKLQQQYQAIETL